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Abstract. We assessed the chnicopatholog1cal characteristics 
of pauents with serrated polyposis syndrome (SPS) and the 
incidence of advanced adenoma/colorectal cancer (CRC). We 
prospectively enrolled 249 consecutive patients who under-
went colonoscopy at the National Cancer Center Hospital 
over a 6 month period. All the polyps were diagnosed using 
magni flcation colonoscopy and問section/biopsy.The enrolled 
patients were divided into two groups, i) those ¥vith ;,;5 histo-
logically diagnosed hyperplastic polyps (HPs) proximal to 
the sigmoid colon, with at least 2 polyps >IO mm indiameter 
and i) those withと20HPs distributed throughout the colon. 
The chnical characteristics of the two groups were compared, 
including lifestyle, family history of CRC and colonoscopic 
findings. HPs were identified in 228 patients, of whom 
21 (8.4%) had SPS. All 21 patients hadと20HPs distributed 
throughout the colon, with none having >2 HPs >:I cm m diam-
eter in the right colon Synchronous advanced adenoma/CRC 
was diagnosed in 76/249 (30.5%) patients. The prevalence 
of advanced adenoma/CRC was higher among patients with 
compared to those without SPS (P=0.075). SPS was also asso 
ciated with older age and higher body mass index (BMI). Our 
results suggested that older age and higher BMI are indepen-
dent risk factors for SPS. Advanced adenoma/CRC tended to 
occur more frequently among pauents with compared to those 
without SPS, although the difference was not statistically 
significant. 
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Introduction 
Hyperplastic polyps (HPs) were considered as harmless, wnh 
no potential of progressing to colorectal cancer (CRC) (I) 
Recently, however, serrated polyps (i.e, HPs, sessile serrated 
adenomas and traditional serrated adenomas) were reported to 
progress to CRC via the serrated neoplasm pathway (2-4). Large 
HPs in the right colon have been associated with synchronous 
CRC and have exhibited malignant potential (5・9).
Hyperplastic polyposis syndrome (HPS) is a clinical condi-
lion characterized by the presence of multiple HPs throughout 
the colorectum and has been associated with increased risk of 
CRC. The diagnostic criteria of HPS were first described by 
Burt and Jassσ） in 2000 for the World Health Organization 
(WHO). These criteria we問 recentlyredefined and this condi 
tion is currently referred to as serrated polyposis syndrome 
(SPS). A number of patients have been reported as having CRC 
and concurrent SPS (10 16), suggesting that SPS may be an 
alternative pathway for the development of CRC However, 
SPS has not yet been extensively investigated in Japan and its 
clinical charactensucs, causes and association of SPS to CRC 
have not been adequately evaluated 、
The prevalence of SPS has been reported to悶ngebetween 
0.01 and 0.05%, but has not yet been assessed by magni自cation
chromoendoscopy Accurate detecuon of HPs throughout the 
colorectum depends on the quality of the colonoscop1c exami 
nation, which may be limited by visibility, bowel preparation, 
spraying with indigo carmine dye and magnificationθ） 
We previously investigated the prevalence of SPS by using 
magnification chromoendoscopy. In this study, we aimed to 
evaluate SPS based on WHO clinical criteria nd assess its 
prevalence, clm1copatholog1cal characteristics and association 
with advanced adenoma/CRC 
Material and methods 
Study popu／叩 onWe prospectively enrolled 249 consecu-
tive patients who underwent initial total colonoscopy at 
the National Cancer Center Hospital, Tokyo, fapan, over a 
6-month period. The md1cat1ons for colonoscopy are listed 
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in Table I. Patients were excluded if they had b巴enpreviously 
treated for a colorectal neoplasm at another hospital; if they 
had a personal or family history of familial adenomatous 
polyposis, or any hereditary disease; if they had previously 
undergone a colectomy; or if they regularly used non-steroidal 
anti-inflammatory drugs. 
Informed consent was obtained from al the patients and 
our Institutional Review Board and Institutional Medical 
Ethics Commitees approved the study protocol, which 
adh巴redto the tenets of the Declaration of Helsinki. 
Table I. Indications for colonoscopy. 
Indications No. of patients 
Screening 
Positve fecal occult blood test or melena 
Abdominal symptoms 














Methods. Al the patients underwent initial total colonoscopy 
using a magnifying video colonoscope (PCF-Q240Z; Olympus 
Optical Co., Tokyo, Japan). Spray catheters w巴reused to spray Table I. Clinical characteristics of patients with and without 
indigo carmine dye from the cecum to the rectum in al the SPS. 
patients. The location, size and number of HPs and neoplastic 
lesions were recorded. Al the polyps were diagnosed using 
magnifying colonoscopy and resected or biopsied for his to-
pathological analysis. The enrolled patients were divided into 
two groups based on SPS criteria. Patients were diagnosed 
with SPS if they had <!:20 HPs distributed throughout the 
colon and/or <!:5 histologicaly diagnosed HPs proximal to 
the sigmoid colon, with at least 2 polyps >10 mm in diameter. 
Each patient completed a structured questionnaire, which 
included information on lifestyle and familial history of CRC. 
Lifestyle questions included age弔 gender,body mass index 
(BMI) and the amount and duration of cigarette smoking and 
alcohol consumption during the patient’s lifetime. Smokers 
were de自nedas those having ever smok巴dand drinkers were 
defined those who drankさ30ml alcohol per day for <!:5 years 
(the following assumptions and conversion rates were used: 
I oz was equivalent to 30 ml; I glass of wine contains 120 ml; 
I bottle of beer contains 360 ml; and I drink of hard liquor 
contains 45 ml; the amount of absolute alcohol consumed per 
day was calculated using conversion rates of 10% for wine, 
3.7% for beer and 38% for hard liquor). 
Statistical analyses. Our primary aim was to estimate the 
relative risk, using odds ratio (OR) as an approximation, of 
SPS associated with lifestyle. We calculated the ORs and 
95% confidence intervals associated with age, gender, BMI, 
smoking, alcohol consumption and family history of CRC using 
unconditional multivariate logistic regression analysis. P<0.05 
was considered to indicate a statisticaly significant difference 
and al the tests for statistical significance wer巴two-sided.Al I "First-degree relatives. SPS, serrated polyposis syndrome; BMI, body 
th巴statisticalanalyses were performed using Stata software, mass index; ADA, advanced adenoma; CRC, colorectal cancer. 
version 10 (StataCorp, Colege Station, TX, USA). 
Results 
Patients and lifestyle. Of the 249 patients (I 30 men and 
I 19 women), 228 (91.6%) had HPs; of the latter, 21 (8.4%) had 
SPS, al of whom had <!:20 HPs distributed throughout the 
colon and none having >2 HPsとlcm in diameter in th巴right
colon. 
The clinical characteristics of the patients are summarized 
in Table I. The SPS group consisted of 15 men and 6 women 
(median age, 66 years; median BMI, 23フkg／『n2).The propor-
tion of current alcohol consumers in the SPS and non-SPS 
groups was 0% (0121) and 1.5% (25/228), respectively. There 
SPS Non-SPS 
Characteristics (n=2 I) (n=228) P-value 
BMI く0.01
Median 23.7 22.2 
Range 23.1-25.5 20.0-24.2 
Age, years 0.018 
Median (range) 66 60 
Rang巴 59-70 51-67 
Gender, no.(%) 0.065 
Mal巴 15 (71 .4) 115 (50.4) 
Female 6 (28.6) 113(49.6) 
ADA Ca, no.(%) 0.075 
Pres巴nt 10 (47.6) 66 (28.9) 
Absent 11 (52.4) 162 (71.1) 
Smoking, no.(%) 0.241 
Never 10 (47.6) 148 (62.3) 
Current or ever 1 (52.4) 80 (37.7) 
Alcohol, no.(%) 0.101 
No 21 (100) 203 (88.5) 
Yes 0 (0目0) 25(11.5) 
Family history" 0.54 
of CRC, no.(%) 
Present 2 (9.5) 38 ( 17.6) 
Absent 19 (90.5) 190 (82.4) 
were I smokers in the SPS group (52.4%). Using univariate 
logistic regression analysis, we analyzed the association 
between SPS and 7 independ巴ntvariables, namely age, gender, 
BMI, alcohol consumption, smoking, family history of CRC 
and advanced adenoma ladenomaとlcm; villous compon巳nt
(tubulovi lous or vi lous); and high‘grade dysplasialfCRC. 
Advanced adenoma!CRC. Synchronous advanced 
ad巴noma/CRCwas observed in 76 of the 249 patients (30.5%). 
The OR for synchronous advanced adenoma/CRC was higher 
in patients with compared to those without SPS, but there was 
正ー，
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no significant assoc1at1on between synchronous advanced 
adenoma/CRC and SPS. 
Discussion 
The prevalence of SPS among patients with HPs rn this study 
was 8.4%, which was higher compared to that previously 
observed. This may be attributed to our use of chromoendos-
copy, the most accurate method to date for determining the 
number of HPs. HPs are difficult to detect with convent1onal 
imaging techniques, as their color and appearance are similar 
to those of normal mucosa, unlike typical adenomatous polyps, 
and their vascular network 1s weak, unlike that of hypervas 
cular adenomas. In addition, serrated polyps, mainly sessile 
serrated adenomas, are typically sessile or日at,making their 
detection even more difficult (17). Since these lesions have 
been shown to have malignant potential, particularly rn the 
context of SPS, early endoscopic detection is crucial In this 
regard, novel, more advanced endoscopic techniques, such as 
chromoendoscopy, become important Chromoendoscopy in 
SPS cases should be performed by spraying a contrast dye over 
the entire surface of the colon and using a magnification endo-
scope.τhe most widely used contrast dye is indigo carmine, 
which accumulates川 thepits and innomrnate grooves of 
the colonic mucosa, outlining the borders of flat lesions and 
forming the described Kudo patterns (18). Hyperplastic and 
serrated polyps typically exhibit Kudo type I patterns. 
Published randomized tnals have shown that h1gh-defi 
nition pancolonic chromoendoscopy almost doubles the rate 
of detection of sporadic serrated polyps compared to conven-
t1onal endoscopy (18-23). In these studies, HPs were found 
in 20% of patients undergoing chromoendoscopy vs. 10% 
of those undergoing conventional endoscopy and this differ-
ence was statistically sigm自cant.In addition, our study was 
performed on patients visiting an independent cancer center, 
who would be expected to be at greater risk of CRC compared 
to the general public. 
Two types of diagnost1ccritena were used for the endoscopic 
detection of SPS: i) >:5 HPs, with at least 2 polyps >10 mm in
diameter; and i) the presence of numerous HPs, regardless 
of size. In patients meeting the former criterion, the HPs are 
mainly located in the nght colon, whereas, in those meeting 
the latter, the m吋orityof HPs are located in the left colon. 
All the patients with SPS fulfilled the latter criterion and none 
ful日lledthe former, suggesting that the diagnostic criteria for 
SPS require revision 
In assessing the developmental path of CRC, we found 
that the former criterion for SPS （注5HPs, with at least 
2 polyps >10 mm in diameter) corresponded to the serrated 
pathway By contrast, it has not yet been determined whether 
CRC in patients meeting the latter criterion (numerous HPs, 
regardless of size) develops through the serrated pathway. A 
number of our SPS patients had local lesions, either advanced 
adenoma or CRC, in the left colon. We also observed that the 
incidence of advanced adenoma/CRC was significantly higher 
in patients with multiple small HPs compared to that in patients 
without HPs, indicating that SPS may be a risk factor for CRC. 
Our results suggested that the risk factors for SPS include 
olderage and higher BM!, but not gender, alcohol and smoking 
In another study, however, cigarette smoking was found to be 
strongly associated with SPS, suggesting that smoking may 
increase the occurrence of this condition (24). Although an 
epidemiological study reported associations between CRC and 
alcohol consumption and smoking (25), these findings were 
not confirmed by our study. Not al CRCs arise from SPS, thus, 
SPS should be considered as a risk factor for CRC, even in 
patients who do not smoke or drink. 
We observed that the percentage of patients with a family 
history of CRC was higher in the SPS group compared to that 
in the non-SPS group, although the difference was not statisti-
cally significant Giant HP has been reported as a new familial 
syndrome predisposing to colorectal cancer (26) SPS cntena 
may be useful for identifying patients who should undergo 
screening colonoscopy 
Although the difference was not statistically significant, 
the rate of advanced adenoma/CRC. was higher in the SPS 
compared to that in the non-SPS group. The rate of CRC in the 
entire cohort was higher compared to that previously reported, 
with some of these patients having SPS Thus, patients with 
SPS should be prospectively screened for CRC. 
There we悶 severallimitations to this study. First, al the 
patients were evaluated at a single institution, namely the 
National Cancer Center, Tokyo, Japan, which may have intro-
duced a selection bias. Second, the sample size was relatively 
small, particularly for patients with SPS. Third, the clinical 
charactenst1cs of SPS patients were investigated in an explor-
atory manner and, therefore, cannot be considered to be the 
absolute clinical characteristics of SPS. The strength of this 
study, however, hes with !ls ability to identify HPs with high 
precision. 
In conclusion, our results suggest that the risk factors for 
SPS include older age and higher BM!. The prevalence of 
advanced adenoma/CRC was higher among patients with SPS 
compared to those without SPS, although the difference was 
not statistically significant. 
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